semaglutide side effects shortness of breath Ozempic and GLP-1 Drugs: Risk Severe Semaglutide Side Effects: Common vs

Vitamin D Willett thinks the jury is still out on vitamin E and C and heart health

A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease

Sunagozaka et al

Tirzepatide (Mounjaro/Zepbound) Potential: Newer research reviews (2025) have highlighted Tirzepatidewhich targets both GLP-1 and GIP receptorsas a potential "disease-modifying" therapy

metformin plus phentermine For weight loss specifically, some providers combine metformin with phentermine as a lower-cost alternative

for them, 2600 calories may maintain weight or cause slow loss